Genomenon, Inc.

Biotechnology company · Ann Arbor, Michigan, United States

Genomenon, Inc. is a biotechnology company headquartered in Ann Arbor, Michigan, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.6 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Genomenon at a glance

Typebiotechnology company

HeadquartersAnn Arbor, Michigan, United States

Employees (self-reported, 2021)24

SEC CIK1650557

What does Genomenon do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $3.6 million in total (2017 to 2021). NIH funding came from the National Human Genome Research Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $5.5 million sold (2024).

Frequently asked questions about Genomenon

Where is Genomenon headquartered?

Genomenon, Inc. is headquartered in Ann Arbor, Michigan, United States.

What does Genomenon do?

Genomenon, Inc. is a biotechnology company.

Similar companies

ONL Therapeutics, Inc.Ann Arbor, Michigan, United States
BlueWillow Biologics, Inc.Ann Arbor, Michigan, United States
Altality, Inc.Ann Arbor, Michigan, United States
Nymirum, Inc.Ann Arbor, Michigan, United States
Brio Device LLCAnn Arbor, Michigan, United States
AgelessRx, Inc.Ann Arbor, Michigan, United States
Tsrl, Inc.Ann Arbor, Michigan, United States
Innovative Biotherapies, Inc.Ann Arbor, Michigan, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences